InvestSMART

InteliCare Holdings Limited (ASX: ICR) - Share Price

Current share price for ICR : $0.027 0.001 (3.57%)+

InteliCare Holdings Limited (ICR) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is a Company that is engaged in production of a predictive analytics solution for care providers in the aged care, disability and healthcare sectors, sales and marketing, research and development activities.

ICR General Information +

ASX Code ICR
Website http://www.intelicare.com.au
Industry/Sector Health Care Technology
Market Cap ($M) 19
ICR Share Price $0.027
Day High $0.027
Day Low $0.027
Last Close $0.028
ICR Share Price Movement $0.00 ( 3.57% )
Prices as at 12:35, 3 Sep 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

InteliCare Holdings Limited (ICR) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from InteliCare Holdings Limited (ICR) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

InteliCare Holdings Limited (ICR) price-sensitive announcements

ICR - Response to ASX Price and Volume Query
InteliCare Holdings Limited responded to an ASX query about the recent rise in price and v
InteliCare Holdings Limited (ICR)
25 Aug 2026 | 4:32 PM
ICR - June 2026 Quarterly Activities Report
InteliCare Holdings Ltd reported significant commercial momentum in their June 2026 Quarte
InteliCare Holdings Limited (ICR)
29 Jul 2026 | 8:23 AM
ICR - June 26 Quarterly Cashflow Report
The document is the June 26 Quarterly Cashflow Report of InteliCare Holdings Limited, deta
InteliCare Holdings Limited (ICR)
29 Jul 2026 | 8:23 AM
ICR - Hardi Aged Care Expands Contract
InteliCare Holdings Limited announced an expansion of its commercial agreement with Hardi
InteliCare Holdings Limited (ICR)
28 Jul 2026 | 8:22 AM

InteliCare Holdings Limited (ICR) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
InteliCare Holdings Limited (ICR)
ORDINARY FULLY PAID
Health Care $19 Change in substantial holding 2 Sep 2026 11:01AM $0.028 $0.027 fallen by 3.57%
InteliCare Holdings Limited (ICR)
ORDINARY FULLY PAID
Health Care $19 Appendix 4E and FY2026 Financial Report 27 Aug 2026 8:55AM $0.029 $0.027 fallen by 6.90%
InteliCare Holdings Limited (ICR)
ORDINARY FULLY PAID
Health Care $19 Response to ASX Price and Volume Query 25 Aug 2026 4:32PM $0.029 $0.027 fallen by 6.90%
InteliCare Holdings Limited (ICR)
ORDINARY FULLY PAID
Health Care $19 June 2026 Quarterly Activities Report 29 Jul 2026 8:23AM $0.021 $0.027 risen by 28.57%
InteliCare Holdings Limited (ICR)
ORDINARY FULLY PAID
Health Care $19 June 26 Quarterly Cashflow Report 29 Jul 2026 8:23AM $0.021 $0.027 risen by 28.57%
InteliCare Holdings Limited (ICR)
ORDINARY FULLY PAID
Health Care $19 Hardi Aged Care Expands Contract 28 Jul 2026 8:22AM $0.018 $0.027 risen by 50%

ICR Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026A -$2.10 -$0.40 -28.60% 0.00 0.00 0.00% 0.0%
2025A -$2.24 -$0.50 -51.00% 0.00 0.00 0.00% 0.0%
2024A -$2.26 -$1.00 -44.40% 0.00 0.00 0.00% 0.0%

ICR Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 A 2026 A 2024 A 2025 A 2026 A 2024 A 2025 A 2026 A
4DMedical Limited (4DX) $2,052M 1.4982 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
InteliCare Holdings Limited (ICR) $20M -0.5100 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Pro Medicus Limited (PME) $18,431M 1.3034 -0.2811 0.2395 69.5662 96.7692 78.0689 0.39% 0.52% 0.65%

ICR Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 16.50 0.00
Market 0.38 13.40 1.16 0.81
Sector 0.62 20.60 1.91 2.69

ICR Directors

Name Position Start Date
Dr Neale William Fong Non-Executive Chairman, Non-Executive Director 21 Apr 2022
Mr Timothy (Tim) Chapman Non-Executive Director 25 Sep 2024
Mr Greg Leach Non-Executive Director 1 Jan 0001

InteliCare Holdings Limited (ICR) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
15 Dec 2025 CHAPMAN, Timothy (Tim) Issued Related Securities 6,000,000 $0.020 $120,000.000
15 Dec 2025 LEACH, Greg Issued Related Securities 4,500,000 $0.018 $80,000.000
15 Dec 2025 FONG, Neale Issued Related Securities 4,500,000 $0.018 $80,000.000

See all changes in directors' interest & trades for InteliCare Holdings Limited (ICR) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

ICR Management

Name Position
Daniel Pilbrow Chief Executive Officer
Mike Tappenden Chief Technology Officer
Neil John Hackett Company Secretary

ICR Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in InteliCare Holdings Limited (ICR). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
33,060,387 (5.43%) Melbourne Securities Corporation Limited
30,936,145 (5.01%) Citicorp Nominees Pty Limited

ICR Calendar of Events

Date Event
26 August 2027 Report (Prelim)
26 February 2027 Report (Interim)
19 October 2026 Report (Annual)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.